CDSCO tightens compliance rules

CDSCO tightens compliance rules: Pharma firms must respond within 30 days or face rejection

A major regulatory move that could significantly impact India’s pharma approval ecosystem.

The Central Drugs Standard Control Organisation has announced that pharmaceutical companies must respond to regulatory queries related to drug approval applications within 30 days, failing which the applications will be rejected and fees forfeited.

📌 What’s changing?

Applicable to applications submitted through the SUGAM portal

CDSCO will issue three reminders before final rejection

Non-responsive applications may now be permanently closed

⚠️ Why CDSCO introduced this rule:
The regulator aims to clear a large backlog of pending applications dating back to 2016 across areas such as:

Clinical trials
BA/BE studies
Ethics committee approvals
Veterinary drug applications

🏭 Impact on pharma companies:

Faster regulatory coordination will become essential
Delayed responses could mean loss of both time and application fees
Smaller companies may face pressure to strengthen compliance systems

🌍 Bigger picture:
This move reflects India’s push towards a more structured and globally aligned regulatory environment, similar to agencies like the US FDA and the EMA.

💡 Why this matters:
Efficient regulatory processing can:
✔ Reduce approval delays
✔ Improve investor confidence
✔ Accelerate product launches
✔ Strengthen India’s global pharma competitiveness

Comments

Curated Compendium of Drug Discovery

Drug discovery is a multidisciplinary process that integrates biology, chemistry, pharmacology , and cutting-edge technologies to identify and develop new therapeutic agents. From target identification to lead optimization and clinical evaluation, each stage requires precision, innovation, and collaboration. A curated list of drug discovery resources provides researchers, students, and professionals with a structured pathway to explore advancements, tools, and strategies that shape modern therapeutics. This compilation serves as a gateway to understanding the evolution of drug discovery, recent breakthroughs, and future directions, fostering knowledge-sharing and accelerating translational research. Databases and Chemical Libraries General Compound Libraries DrugBank - Comprehensive data on approved and investigational drugs. ZINC - Free compounds for screening. ChemSpider - Chemical structures and data. DrugSpaceX - Chemical and biological spaces. Mcule ...

Understanding NMR Spectroscopy and Chemical Shift Ranges for Functional Groups

Nuclear Magnetic Resonance ( NMR ) spectroscopy is one of the most powerful analytical tools in pharmaceutical chemistry. It helps chemists determine the structure, purity, and chemical environment of molecules by analyzing the behavior of nuclei (commonly ¹H or ¹³C ) when exposed to a strong magnetic field. In proton NMR ( ¹H-NMR ), the chemical shift (δ, in ppm) provides information about the type of hydrogen atoms present in a compound and their surrounding electronic environment. Depending on nearby atoms and functional groups, signals appear in specific regions of the spectrum — often referred to as upfield (shielded, lower δ values) or downfield (deshielded, higher δ values). The image above summarizes the characteristic δ ranges for different functional groups in ¹H-NMR. Let us break it down systematically: 1. Downfield Region (δ 12 – 6 ppm) Hydrogens in this region are strongly deshielded due to electronegative atoms or π-bond systems. Carboxylic Acids (–COOH) : δ 1...

Pushing the boundaries of computational drug discovery at Isomorphic Labs

The Isomorphic Labs Drug Design Engine (IsoDDE) has unlocked a new frontier in in-silico drug design, representing a significant evolution beyond AlphaFold 3. What IsoDDE delivers: 🔹 Massive accuracy leap on unconstrained structure prediction The engine more than doubles AlphaFold 3's accuracy on extremely challenging protein-ligand prediction tasks — including systems far outside the training distribution. 🔹 Best-in-class binding affinity prediction IsoDDE predicts how strongly small molecules bind to targets with accuracy that exceeds gold-standard physics-based methods, at a fraction of the computational cost and time. 🔹 Blind identification of novel binding pockets Even without existing structural data, the engine reveals previously unseen binding sites — just from an amino acid sequence — enabling drug designers to explore entirely new chemical action spaces. 🔹 Expanded support for complex biologics Beyond small molecules, the engine boosts prediction fidelity for...

NEOPHARMA NUTSHELL COMMUNITY

Search This Blog